2019 annual financial data

XTL Biopharmaceuticals Ltd. 2019 Operating margin

XTL Biopharmaceuticals Ltd. 2019 operating margin with verified reported values.

Direct answer

Operating margin was -1,220.29%.

Operating income was -842,000 USD and net income was -1,347,000 USD.
Operating cash flow was -908,000 USD.

Get free XTL Biopharmaceuticals Ltd. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
69,000 USD
Operating income
-842,000 USD
Net income
-1,347,000 USD
Operating cash flow
-908,000 USD